Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC MCC950 | 210826-40-7 | 99.8% | 200 MG
SDP

Catalog No. 5000342336
Encompass_Preferred

MCC950 is a potent and selective NLRP3 inhibitor, with IC50s of 7.5 and 8.1 nM in BMDMs and HMDMs. It blocks canonical and non-canonical NLRP3 activation at nanomolar concentrations. This product is for research use only.

  • Potent and selective NLRP3 inhibitor
  • Blocks canonical and non-canonical NLRP3 activation
  • Specifically inhibits NLRP3, not AIM2, NLRC4, or NLRP1
  • Reduces interleukin-1β (IL-1β) production
  • Attenuates the severity of experimental autoimmune encephalomyelitis (EAE)

Catalog No. 50-003-42336 Supplier Medchemexpress LLC Supplier No. HY12815200MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

MCC950 is a potent and selective NLRP3 inhibitor, with IC50s of 7.5 and 8.1 nM in BMDMs and HMDMs. It blocks canonical and non-canonical NLRP3 activation at nanomolar concentrations. This product is for research use only.

  • Potent and selective NLRP3 inhibitor
  • Blocks canonical and non-canonical NLRP3 activation
  • Specifically inhibits NLRP3, not AIM2, NLRC4, or NLRP1
  • Reduces interleukin-1β (IL-1β) production
  • Attenuates the severity of experimental autoimmune encephalomyelitis (EAE)

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.